Lunersee
by
Book Cover & Preview Text
Formats
Book Details
About the Book
Buried Nazi treasure, intelligence tradecraft, assassination methods, romance, tragedy and an unsolved mystery are all a part of this novel.
Lunersee: The story has elements of truth throughout. In April 1945 in the closing months of World War II in Europe, many Nazis and SS officers were going into hiding or attempting to flee to the Mideast or South America. Some SS officers who were at the Nazi detah camp at Dachau accumulated much gold, melted down from teeth of the prisoners, and other valuables.
There were some officers who fled Dachau with several containers of gold, precious stones and other valuables and eventually buried it at Lunersee, near the Austrian-Swiss border. They then crossed over into Switzerland, planning on returning someday to reclaim it.
The story then becomes more complicated with the involvement of American Intelligence, Israeli intelligence (MOSSAD), Arab terrorists and the returning ex-Nazis.
It is not just a hodge-podge of incidents thrown together but an actual fitting together of a series of events culminating in an "explosive ending" and a surprise outcome in Lugano Switzerland.
The story has already been reviewed by the Central Intelligence Agency. The reviewers all were impressed by its authenticity insofar as tradecraft is concerned. Many characters in the story actually existed and "the gold is still there."
About the Author
The author is a true "Cold War Warrior" having served as a US military police officer in Europe and as a Central Intelligence Agency senior executive during the "Cold War". While stationed in Munich, Germany after the war, he became very familiar with the death camp at nearby Dachau and provided an authentic description of the activities there. His story of the gold treasure from there has been authenticated by interrogation reports now in the US Archives. Since retiring from the CIA, the author entered the business world as a Wall Street analyst, as a venture capitalist and as a registered money manager, primarily involved with medical technology stocks.